Boston Scientific Corporation (NYSE:BSX) closed its last session at $27.43. The stock traded within a range of $27.16 and $27.99. The company operates in the Healthcare sector with a market capitalization of 37.63 Million. Trading volume for Boston Scientific Corporation was 8.98 Million in its previous trading session. Currently, Boston Scientific Corporation (NYSE:BSX) has an average volume of 8.98 Million.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; other coronary therapy products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral arterial disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors.
Boston Scientific Corporation (NYSE:BSX) received a Buy rating from 4 analysts. 0 analysts gave its stock an Outperform rating. 5 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.
Boston Scientific Corporation (NYSE:BSX) touched its 1-Year High price of $29.93 on 10/23/17 and its 1-Year Low price of $23.03 on 02/23/17.
EPS & Financials
Boston Scientific Corporation (NYSE:BSX) reported its EPS in the last quarter as $0.31/Share lagging the analyst estimate of $0.31/Share by a difference of $0. This showed a surprise of 0% in the last quarter earnings.
For the current quarter, 22 analysts are projecting a mean EPS of $0.34/share. According to their observations and findings, the stock could provide a high EPS of $0.35/share and a low EPS of $0.32/share.
Analysts believe that the company has the potential to earn average revenue of $2.36 Billion for the current quarter. According to their predictions high & low revenue estimates are 2.41 Billion and 2.32 Billion respectively.
By taking a look at the stock’s current statistics it can gauged that the stock candle is BEARISH with HIGH volatility. Boston Scientific Corporation (NYSE:BSX) has a 20-Day average volume of 9.34 Million. According to today’s trading volume Boston Scientific Corporation is BELOW its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.
Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BULLISH territory while an analysis of the last 40-Day trend shows a BEARISH signal. The 100-Day trend also shows a BEARISH trend as well.
The company currently has an insider ownership of 0.1 Percent and Institutional ownership of 94.3 Percent. The return on assets stands at 4.6%, Return on Equity currently is 11.8% and the Return on Investment value is 5.1%.
Boston Scientific Corporation (NYSE:BSX) gross margin percentage stands at 71.8% while its operating margin for the past trailing twelve month is 12.5 percent and its overall profit margin (ttm) is 9.5 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 6.87% with a 50-Day Simple Moving Average of 2.82 percent. As of today, the company has a SMA200 (200-day simple moving average) of 1 Percent. The Stock has YTD (year to date) performance of 10.65 percent.
The TTM operating margin for the company stands at 12.5%. The return on invested capital is at 5.1%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 47.1.
The company’s stock is currently moving with a +ve distance from the 200 day SMA of approximately 1%, and has a solid year to date (YTD) performance of 10.65% which means that the stock is constantly adding to its value from the previous fiscal year end price.